Patents by Inventor Bi Xu

Bi Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations of antibody molecules to influenza virus
    Patent number: 12202885
    Abstract: This disclosure relates to formulations of peptide agents, e.g., antibodies and antigen-binding fragments thereof, that bind hemagglutinin protein of influenza viruses, and methods of their use.
    Type: Grant
    Filed: November 6, 2020
    Date of Patent: January 21, 2025
    Assignee: VISTERRA, INC.
    Inventors: Susan Sloan, Bi Xu
  • FORMULATIONS OF ANTIBODY MOLECULES TO DENGUE VIRUS
    Publication number: 20240366758
    Abstract: This disclosure relates to formulations of peptide agents, e.g., antibodies and antigen-binding fragments thereof, that bind dengue viruses, and methods of their use.
    Type: Application
    Filed: January 23, 2024
    Publication date: November 7, 2024
    Inventors: Catherine Hay, Susan Sloan, Bi Xu
  • Formulations of antibody molecules to dengue virus
    Patent number: 11918651
    Abstract: Formulations of peptide agents, such as antibodies and antigen-binding fragments thereof, that bind dengue viruses, and methods of their use, are provided.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: March 5, 2024
    Assignee: VISTERRA, INC.
    Inventors: Catherine Hay, Susan Sloan, Bi Xu
  • FORMULATIONS OF ANTIBODY MOLECULES TO INFLUENZA VIRUS
    Publication number: 20210054053
    Abstract: This disclosure relates to formulations of peptide agents, e.g., antibodies and antigen-binding fragments thereof, that bind hemagglutinin protein of influenza viruses, and methods of their use.
    Type: Application
    Filed: November 6, 2020
    Publication date: February 25, 2021
    Inventors: Susan Sloan, Bi Xu
  • FORMULATIONS OF ANTIBODY MOLECULES TO DENGUE VIRUS
    Publication number: 20200237913
    Abstract: This disclosure relates to formulations of peptide agents, e.g., antibodies and antigen-binding fragments thereof, that bind dengue viruses, and methods of their use.
    Type: Application
    Filed: October 8, 2019
    Publication date: July 30, 2020
    Inventors: Catherine Hay, Susan Sloan, Bi Xu
  • FORMULATIONS OF ANTIBODY MOLECULES TO INFLUENZA VIRUS
    Publication number: 20200181243
    Abstract: This disclosure relates to formulations of peptide agents, e.g., antibodies and antigen-binding fragments thereof, that bind hemagglutinin protein of influenza viruses, and methods of their use.
    Type: Application
    Filed: July 22, 2019
    Publication date: June 11, 2020
    Inventors: Susan Sloan, Bi Xu
  • FORMULATIONS OF ANTIBODY MOLECULES TO DENGUE VIRUS
    Publication number: 20170274076
    Abstract: This disclosure relates to formulations of peptide agents, e.g., antibodies and antigen-binding fragments thereof, that bind dengue viruses, and methods of their use.
    Type: Application
    Filed: March 24, 2017
    Publication date: September 28, 2017
    Applicant: VISTERRA, INC.
    Inventors: Catherine Hay, Susan Sloan, Bi Xu
  • FORMULATIONS OF ANTIBODY MOLECULES TO INFLUENZA VIRUS
    Publication number: 20170240617
    Abstract: This disclosure relates to formulations of peptide agents, e.g., antibodies and antigen-binding fragments thereof, that bind hemagglutinin protein of influenza viruses, and methods of their use.
    Type: Application
    Filed: February 23, 2017
    Publication date: August 24, 2017
    Inventors: Susan Sloan, Bi Xu